相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration
Christa M. Cobbaert et al.
CLINICAL CHEMISTRY (2021)
Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LDL-C estimation
Agnieszka Cwiklinska et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases
Anna Wolska et al.
CELLS (2021)
Association of Increased Remnant Cholesterol and the Risk of Coronary Artery Disease: A Retrospective Study
Wang Kexin et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study
Renato Quispe et al.
EUROPEAN HEART JOURNAL (2021)
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg et al.
EUROPEAN HEART JOURNAL (2021)
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group
Peter W. F. Wilson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2021)
Non-HDL-C/TG ratio indicates significant underestimation of calculated low-density lipoprotein cholesterol (LDL-C) better than TG level: a study on the reliability of mathematical formulas used for LDL-C estimation
Agnieszka Cwiklinska et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg et al.
EUROPEAN HEART JOURNAL (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
Robert A. Hegele et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Clinical review on triglycerides
Ulrich Laufs et al.
EUROPEAN HEART JOURNAL (2020)
Evaluating the need for free glycerol blanking for serum triglyceride measurements at Charlotte Maxeke Johannesburg Academic Hospital
Carla van Heerden et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
Michel R. Langlois et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Human apolipoprotein CIII levels; evaluation of three assay methods
Asa Sandin et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2020)
ApoB48-remnant lipoproteins are associated with increased cardiometabolic risk in adolescents
Jacqueline A. Krysa et al.
ATHEROSCLEROSIS (2020)
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Jan Boren et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Comparison of calculated remnant lipoprotein cholesterol levels with levels directly measured by nuclear magnetic resonance
Jin Chen et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Hypertriglyceridemia-Causes, Significance, and Approaches to Therapy
Leinys S. Santos-Baez et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
A Comprehensive Update on the Chylomicronemia Syndrome
Ronald B. Goldberg et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Experimental Therapeutics for Challenging Clinical Care of a Patient with an Extremely Rare Homozygous APOC2 Mutation
Masako Ueda et al.
CASE REPORTS IN ENDOCRINOLOGY (2020)
2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders
Bogdan Solnica et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
Pratik B. Sandesara et al.
ENDOCRINE REVIEWS (2019)
The Diagnosis and Treatment of Hypertriglyceridemia
Klaus G. Parhofer et al.
DEUTSCHES ARZTEBLATT INTERNATIONAL (2019)
Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
Archna Bajaj et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2019)
Fasting apolipoprotein B48 is associated with large artery atherosclerotic stroke: a case-control study
Jing Tian et al.
SCIENTIFIC REPORTS (2019)
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R. Langlois et al.
CLINICAL CHEMISTRY (2018)
A comparison of three apolipoprotein B methods and their associations with incident coronary heart disease risk over a 12-year follow-up period: The Multi-Ethnic Study of Atherosclerosis
Jing Cao et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization
Vincent Delatour et al.
CLINICAL CHEMISTRY (2018)
Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?
Michel R. Langlois et al.
CURRENT CARDIOLOGY REPORTS (2018)
Kinetics of plasma triglycerides in abdominal obesity
Elias Bjornson et al.
CURRENT OPINION IN LIPIDOLOGY (2017)
Obesity pandemic: causes, consequences, and solutions-but do we have the will?
David R. Meldrum et al.
FERTILITY AND STERILITY (2017)
A Novel APOC2 Missense Mutation Causing Apolipoprotein C-II Deficiency With Severe Triglyceridemia and Pancreatitis
Masako Ueda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Hypertriglyceridemia and atherosclerosis
Jia Peng et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism
Anna Wolska et al.
ATHEROSCLEROSIS (2017)
Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping
Irene van den Broek et al.
CLINICAL CHEMISTRY (2016)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Novel therapies for severe dyslipidemia originating from human genetics
Daniel Gaudet
CURRENT OPINION IN LIPIDOLOGY (2016)
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
Andres Digenio et al.
DIABETES CARE (2016)
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2016)
Knowledge and perception about health risks of cigarette smoking among Iraqi smokers
Omar Thanoon Dawood et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2016)
Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity Multicenter Tracer Kinetic Study
Jan Boren et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population
Anette Varbo et al.
CLINICAL CHEMISTRY (2015)
Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
Charles Daniel Meyers et al.
LIPIDS IN HEALTH AND DISEASE (2015)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Fasting and Nonfasting Triglycerides in Cardiovascular and Other Diseases
J. Pitha et al.
PHYSIOLOGICAL RESEARCH (2015)
Identifying pseudohypertriglyceridemia in clinical practice
James M. Backes et al.
CLINICAL LIPIDOLOGY (2014)
Triglycerides and cardiovascular disease
Borge G. Nordestgaard et al.
LANCET (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Remnant cholesterol as a cause of ischemic heart disease: Evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment
Anette Varbo et al.
PHARMACOLOGY & THERAPEUTICS (2014)
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
Robert A. Hegele et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Fasting serum concentration of apolipoprotein B48 represents residual risks in patients with new-onset and chronic coronary artery disease
Kenta Mori et al.
CLINICA CHIMICA ACTA (2013)
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Anette Varbo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Reference Measurement Procedure for Total Glycerides by Isotope Dilution GC-MS
Selvin H. Edwards et al.
CLINICAL CHEMISTRY (2012)
Exploring the value of apoB48 as a marker for atherosclerosis in clinical practice
Arash Alipour et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence
Daisaku Masuda et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Lipid-Related Markers and Cardiovascular Disease Prediction
Emanuele Di Angelantonio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Prevalence of lipid abnormalities in the United States: The National Health and Nutrition Examination Survey 2003-2006
Peter P. Toth et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease
Anastazia A. Kei et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Nonfasting Triglycerides, Cholesterol, and Ischemic Stroke in the General Population
Anette Varbo et al.
ANNALS OF NEUROLOGY (2011)
Proposed Serum Cholesterol Reference Measurement Procedure by Gas Chromatography-Isotope Dilution Mass Spectrometry
Selvin H. Edwards et al.
CLINICAL CHEMISTRY (2011)
Apolipoproteins: metabolic role and clinical biochemistry applications
Marek H. Dominiczak et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2011)
Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
Chunyu Zheng et al.
CIRCULATION (2010)
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
LANCET (2010)
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
Min Jun et al.
LANCET (2010)
Current concepts in triglyceride metabolism, pathophysiology, and treatment
Georges AbouRjaili et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Severe hypertriglyceridemia and pancreatitis: presentation and management
Nils Ewald et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
Anne Hiukka et al.
DIABETES (2009)
Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III
Doris T. Chan et al.
JOURNAL OF LIPID RESEARCH (2009)
Meta-Analysis of the Relationship Between Non-High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
Jennifer G. Robinson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Atorvastatin and fenofibrate have comparable effects on VLDL - Apolipoprotein C-III kinetics in men with the metabolic syndrome
Dick C. Chan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Esther M. M. Ooi et al.
CLINICAL SCIENCE (2008)
Association of serum apolipoprotein B48 level with the presence of carotid plaque in type 2 diabetes mellitus
Kyoko Tanimura et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Plasma apolipoprotein C-III transport in centrally obese men: Associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism
Dick C. Chan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Standardization of measurements for cholesterol, triglycerides, and major lipoproteins
G. Russell Warnick et al.
LABMEDICINE (2008)
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Borge G. Nordestgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappa B activation
Akio Kawakami et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease
Jian Liu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Evaluation of new apolipoprotein C-II and apolipoprotein C-III automatized immunoturbidimetric kits
Alain Nicolay et al.
CLINICAL BIOCHEMISTRY (2006)
Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes
J Liu et al.
DIABETES CARE (2005)
Plasma lipoprotein lipase, hepatic lipase activities, VLDL, LDL compositions at different times of hemodialysis
K Mekki et al.
ATHEROSCLEROSIS (2003)
Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patients
AM Wägner et al.
DIABETES CARE (2003)
Identification of a lipoprotein lipase cofactor-binding site by chemical cross-linking and transfer of apolipoprotein C-II-responsive lipolysis from lipoprotein lipase to hepatic lipase
TL McIlhargey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA
N Sakai et al.
JOURNAL OF LIPID RESEARCH (2003)
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
K Olin-Lewis et al.
JOURNAL OF LIPID RESEARCH (2002)
Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III, and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level
I Sakurabayashi et al.
CLINICA CHIMICA ACTA (2001)
Hydrolysis of phospholipids by purified milk lipoprotein lipase - Effect of apoprotein CII, CIII, A and E, and synthetic fragments
DA Lambert et al.
CLINICA CHIMICA ACTA (2000)
分享论文
